Jiangsu Bioperfectus Ownership

688399 Stock   70.20  0.17  0.24%   
Jiangsu Bioperfectus Technologies has a total of 56.67 Million outstanding shares. Jiangsu Bioperfectus secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Jiangsu Bioperfectus in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Jiangsu Bioperfectus, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of November 30, 2024, Dividends Paid is expected to decline to about 5.7 M. The current year's Net Income Applicable To Common Shares is expected to grow to about 2.2 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 59.9 M.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Jiangsu Bioperfectus Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Jiangsu Stock Ownership Analysis

About 49.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.21. In the past many companies with similar price-to-book ratios have beat the market. Jiangsu Bioperfectus recorded a loss per share of 2.92. The entity last dividend was issued on the 30th of May 2022. For more info on Jiangsu Bioperfectus Technologies please contact the company at 86 52 3802 25599 or go to https://www.s-sbio.com.

Jiangsu Bioperfectus Outstanding Bonds

Jiangsu Bioperfectus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Jiangsu Bioperfectus uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Jiangsu bonds can be classified according to their maturity, which is the date when Jiangsu Bioperfectus Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Jiangsu Stock

Jiangsu Bioperfectus financial ratios help investors to determine whether Jiangsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jiangsu with respect to the benefits of owning Jiangsu Bioperfectus security.